• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于自动试剂盒的PCR系统检测非小细胞肺癌患者血浆中的表皮生长因子受体(EGFR)突变

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.

作者信息

Heeke Simon, Hofman Véronique, Benzaquen Jonathan, Otto Josiane, Tanga Virginie, Zahaf Katia, Allegra Maryline, Long-Mira Elodie, Lassalle Sandra, Marquette Charles-Hugo, Ilie Marius, Hofman Paul

机构信息

Department of Thoracic H&N Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States.

Laboratory of Clinical and Experimental Pathology, Biobank BB-0033-00025, Centre Hospitalier Universitaire Nice, Nice, France.

出版信息

Front Pharmacol. 2021 Apr 14;12:657743. doi: 10.3389/fphar.2021.657743. eCollection 2021.

DOI:10.3389/fphar.2021.657743
PMID:33935776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8079969/
Abstract

The introduction of liquid biopsies for the detection of mutations in non-small cell lung cancer patients (NSCLC) has revolutionized the clinical care. However, liquid biopsies are technically challenging and require specifically trained personnel. To facilitate the implementation of liquid biopsies for the detection of mutations from plasma, we have assessed a fully automated cartridge-based qPCR test that allows the automatic detection of mutations directly from plasma. We have analyzed 54 NSCLC patients and compared the results of the cartridge-base device to an FDA-approved assay. Detection of EGFR mutations was comparable but slightly lower in the cartridge-based device for L858R mutations (14/15 detected, 93%) and exon 19 deletions (18/20 detected, 90%). Unfortunately, 8/54 (15%) tests failed but increasing the proteinase K volume helped to recover 3/4 (75%) unsuccessful samples. In summary, the fully automated cartridge-based device allowed the detection of EGFR mutations directly from plasma in NSCLC patients with promising accuracy. However, protocol adjustments are necessary to reduce a high test failure rate.

摘要

液体活检用于检测非小细胞肺癌(NSCLC)患者的突变,这一技术的引入彻底改变了临床护理方式。然而,液体活检在技术上具有挑战性,需要经过专门培训的人员。为了便于实施通过血浆检测突变的液体活检技术,我们评估了一种基于盒式装置的全自动定量聚合酶链反应(qPCR)检测方法,该方法可直接从血浆中自动检测突变。我们分析了54例NSCLC患者,并将基于盒式装置的检测结果与一种经美国食品药品监督管理局(FDA)批准的检测方法的结果进行了比较。对于L858R突变(检测到14/15,93%)和外显子19缺失(检测到18/20,90%),基于盒式装置的EGFR突变检测结果相当,但略低。不幸的是,8/54(15%)的检测失败,但增加蛋白酶K的用量有助于挽救3/4(75%)未成功的样本。总之,基于盒式装置的全自动检测方法能够直接从NSCLC患者的血浆中检测EGFR突变,准确性令人满意。然而,需要对方案进行调整以降低高检测失败率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/abbd2a4dae22/fphar-12-657743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/7d2704520de7/fphar-12-657743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/142dc48262df/fphar-12-657743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/abbd2a4dae22/fphar-12-657743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/7d2704520de7/fphar-12-657743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/142dc48262df/fphar-12-657743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0037/8079969/abbd2a4dae22/fphar-12-657743-g003.jpg

相似文献

1
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.使用基于自动试剂盒的PCR系统检测非小细胞肺癌患者血浆中的表皮生长因子受体(EGFR)突变
Front Pharmacol. 2021 Apr 14;12:657743. doi: 10.3389/fphar.2021.657743. eCollection 2021.
2
Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).在非小细胞肺癌中常规临床实践中液体活检 EGFR 状态检测的关键评估:单实验室经验(法国尼斯 LPCE)。
Clin Lung Cancer. 2020 Jan;21(1):56-65.e8. doi: 10.1016/j.cllc.2019.07.010. Epub 2019 Aug 3.
3
Is the Idylla Mutation Assay feasible on archival stained cytological smears? A pilot study.Idylla 基因突变检测在存档染色细胞学涂片上是否可行?一项初步研究。
J Clin Pathol. 2019 Sep;72(9):609-614. doi: 10.1136/jclinpath-2019-205863. Epub 2019 May 20.
4
mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla Mutation Assay.通过基于新型全自动PCR的Idylla突变检测法对肺癌细胞学标本进行突变检测。
J Clin Pathol. 2017 Apr;70(4):295-300. doi: 10.1136/jclinpath-2016-203989. Epub 2016 Aug 19.
5
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma.一种用于检测尿液和血浆中 NSCLC EGFR 突变的高灵敏度和定量检测平台。
J Thorac Oncol. 2016 Oct;11(10):1690-700. doi: 10.1016/j.jtho.2016.05.035. Epub 2016 Jul 25.
6
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.采用基于芯片的数字PCR系统对晚期非小细胞肺癌患者进行血浆表皮生长因子受体突变检测。
Lung Cancer. 2017 Apr;106:138-144. doi: 10.1016/j.lungcan.2017.02.001. Epub 2017 Feb 4.
7
Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study.质谱分析法作为非小细胞肺癌中特定循环肿瘤DNA分析的高灵敏度方法:一项比较研究
Cancers (Basel). 2020 Oct 16;12(10):3002. doi: 10.3390/cancers12103002.
8
EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.使用全自动Idylla™ qPCR系统对非小细胞肺癌组织样本进行表皮生长因子受体(EGFR)突变分析。
Methods Mol Biol. 2019;2054:147-155. doi: 10.1007/978-1-4939-9769-5_10.
9
Evaluation of a fast and fully automated platform to diagnose and mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.评估一个快速且全自动的平台,用于在不到一天的时间内诊断福尔马林固定石蜡包埋的非小细胞肺癌样本中的突变情况。
J Clin Pathol. 2017 Jun;70(6):544-549. doi: 10.1136/jclinpath-2016-204202. Epub 2017 Feb 2.
10
Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology.利用新型突变富集液芯芯片(MEL)技术检测非小细胞肺癌(NSCLC)中的 EGFR 体细胞突变。
Curr Drug Metab. 2012 Sep 1;13(7):1007-11. doi: 10.2174/138920012802138660.

引用本文的文献

1
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France).胸科肿瘤液体活检临床实践的实施:法国尼斯RespirERA大学医院研究所的经验
J Liq Biopsy. 2023 Aug 16;1:100004. doi: 10.1016/j.jlb.2023.100004. eCollection 2023 Sep.
2
[The concept of the liquid biopsy in the treatment of malignant eye tumours].[液体活检在恶性眼肿瘤治疗中的概念]
Ophthalmologie. 2024 Dec;121(12):946-953. doi: 10.1007/s00347-024-02132-3. Epub 2024 Nov 8.
3
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives.

本文引用的文献

1
Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.使用来自一组高度特征化的突变阳性样本的预提取DNA对Biocartis Idylla表皮生长因子受体(EGFR)突变检测进行性能评估。
J Clin Pathol. 2022 Apr;75(4):241-249. doi: 10.1136/jclinpath-2020-207338. Epub 2021 Jan 29.
2
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.晚期 NSCLC 中循环肿瘤 DNA 水平的基因型特异性差异。
J Thorac Oncol. 2021 Apr;16(4):601-609. doi: 10.1016/j.jtho.2020.12.011. Epub 2020 Dec 31.
3
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
肺癌的液体活检与组织活检:算法与展望
Cancers (Basel). 2024 Sep 29;16(19):3340. doi: 10.3390/cancers16193340.
4
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.液体活检在 T 细胞淋巴瘤中的应用:生物标志物检测技术及临床应用。
Mol Cancer. 2024 Feb 17;23(1):36. doi: 10.1186/s12943-024-01947-7.
5
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma.三种不同技术在晚期肺腺癌患者液体活检中检测 EGFR 突变的比较。
Int J Mol Sci. 2023 Mar 29;24(7):6410. doi: 10.3390/ijms24076410.
6
Clinical application and detection techniques of liquid biopsy in gastric cancer.液体活检在胃癌中的临床应用及检测技术。
Mol Cancer. 2023 Jan 11;22(1):7. doi: 10.1186/s12943-023-01715-z.
7
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer.癌基因依赖型非小细胞肺癌的形态-分子转化。
Int J Mol Sci. 2022 Apr 9;23(8):4164. doi: 10.3390/ijms23084164.
8
Daily Practice Assessment of Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner.非小细胞肺癌患者病情的日常实践评估:胸科病理学家面临的一项新挑战即将来临。
Cancers (Basel). 2022 Mar 23;14(7):1628. doi: 10.3390/cancers14071628.
9
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.液体活检在肺癌中的应用:在诊断、预测和治疗监测中的意义。
Mol Cancer. 2022 Jan 20;21(1):25. doi: 10.1186/s12943-022-01505-z.
10
Contribution of the Idylla System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of Mutations.Idylla 系统通过早期筛查突变对改善 NSCLC 患者治疗护理的贡献。
Curr Oncol. 2021 Nov 3;28(6):4432-4445. doi: 10.3390/curroncol28060376.
全面跨平台比较非侵入性 EGFR 突变检测方法:RING 观察性试验结果。
Mol Oncol. 2021 Jan;15(1):43-56. doi: 10.1002/1878-0261.12832. Epub 2020 Nov 13.
4
Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.在临床实践中成功实施基于血浆的 NSCLC 基因分型的策略。
Nat Rev Clin Oncol. 2021 Jan;18(1):56-62. doi: 10.1038/s41571-020-0423-x. Epub 2020 Sep 11.
5
Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).在非小细胞肺癌中常规临床实践中液体活检 EGFR 状态检测的关键评估:单实验室经验(法国尼斯 LPCE)。
Clin Lung Cancer. 2020 Jan;21(1):56-65.e8. doi: 10.1016/j.cllc.2019.07.010. Epub 2019 Aug 3.
6
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients.肿瘤突变负荷检测的内部实施,以预测非小细胞肺癌和黑色素瘤患者的持久临床获益
Cancers (Basel). 2019 Aug 29;11(9):1271. doi: 10.3390/cancers11091271.
7
Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition.非小细胞肺癌中血浆 EGFR 突变检测:一个价值主张。
Clin Chim Acta. 2019 Aug;495:481-486. doi: 10.1016/j.cca.2019.05.019. Epub 2019 May 21.
8
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌:欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
9
Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.学术临床实验室的外包:病理学主席协会实验室外包调查的经验与教训
Acad Pathol. 2018 Apr 2;5:2374289518765435. doi: 10.1177/2374289518765435. eCollection 2018 Jan-Dec.
10
Optimization of mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.基于全自动定量聚合酶链反应的Idylla系统对非小细胞肺癌患者肿瘤组织中突变检测的优化
Oncotarget. 2017 Oct 4;8(61):103055-103062. doi: 10.18632/oncotarget.21476. eCollection 2017 Nov 28.